Neurocrine Clinical Site

Kansas City, Missouri 64108

Use our guide to learn which trials are right for you!

We've found
2 trials
at this facility
Tardive Dyskinesia (TD) Clinical Trial
Persistence of Effect and Safety of Valbenazine for the Treatment of Tardive Dyskinesia
Status: Enrolling, Phase IV
Updated: 12/31/1969
Neurocrine Clinical Site
mi
from
Kansas City, MO
Click here to add this to my saved trials
Tardive Dyskinesia Clinical Trial
Real‐World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents
Status: Enrolling
Updated: 11/20/2017
Neurocrine Clinical Site
mi
from
Kansas City, MO
Click here to add this to my saved trials